James S, Christoffersen AD, David JP, Hacker M, et al. Effect of Once-Weekly Subcutaneous Semaglutide on Arterial Inflammation in People with Type 2 Diabetes and Cardiovascular Disease Using PET-MRI: Primary Results of a Randomized, Double-Blind, Placebo-Controlled Trial. Am Heart J 2025 May 7:S0002-8703(25)00156-5. doi: 10.1016/j.ahj.2025.
PMID: 40345413